Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Operating Margin 2010-2025 | BMY

Current and historical operating margin for Bristol Myers Squibb (BMY) over the last 10 years. The current operating profit margin for Bristol Myers Squibb as of June 30, 2025 is 28.74%.
  
Bristol Myers Squibb Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $47.70B $6.59B 13.82%
2025-03-31 $47.64B $6.11B 12.82%
2024-12-31 $48.30B $-8.38B -17.35%
2024-09-30 $47.44B $-6.88B -14.50%
2024-06-30 $46.51B $-6.42B -13.80%
2024-03-31 $45.53B $-5.85B -12.84%
2023-12-31 $45.01B $8.44B 18.75%
2023-09-30 $44.94B $8.63B 19.19%
2023-06-30 $45.19B $8.70B 19.25%
2023-03-31 $45.85B $8.80B 19.19%
2022-12-31 $46.16B $7.71B 16.71%
2022-09-30 $46.74B $7.71B 16.50%
2022-06-30 $47.14B $7.66B 16.25%
2022-03-31 $46.96B $7.26B 15.45%
2021-12-31 $46.39B $8.10B 17.46%
2021-09-30 $45.47B $-4.21B -9.26%
2021-06-30 $44.38B $-4.11B -9.26%
2021-03-31 $42.81B $-4.04B -9.43%
2020-12-31 $42.52B $-6.87B -16.16%
2020-09-30 $39.40B $3.45B 8.76%
2020-06-30 $34.86B $2.54B 7.29%
2020-03-31 $31.01B $2.69B 8.68%
2019-12-31 $26.15B $4.98B 19.03%
2019-09-30 $24.17B $6.61B 27.34%
2019-06-30 $23.86B $7.43B 31.13%
2019-03-31 $23.29B $6.17B 26.49%
2018-12-31 $22.56B $5.97B 26.45%
2018-09-30 $22.04B $5.16B 23.42%
2018-06-30 $21.60B $4.18B 19.34%
2018-03-31 $21.04B $4.96B 23.55%
2017-12-31 $20.78B $5.13B 24.70%
2017-09-30 $20.57B $5.52B 26.83%
2017-06-30 $20.24B $5.90B 29.13%
2017-03-31 $19.97B $6.22B 31.13%
2016-12-31 $19.43B $5.92B 30.45%
2016-09-30 $18.47B $4.42B 23.92%
2016-06-30 $17.62B $3.85B 21.84%
2016-03-31 $16.91B $2.28B 13.51%
2015-12-31 $16.56B $2.08B 12.54%
2015-09-30 $16.53B $2.43B 14.68%
2015-06-30 $16.38B $2.45B 14.94%
2015-03-31 $16.11B $2.84B 17.65%
2014-12-31 $15.88B $2.38B 14.99%
2014-09-30 $16.06B $3.31B 20.61%
2014-06-30 $16.21B $3.12B 19.25%
2014-03-31 $16.37B $3.20B 19.57%
2013-12-31 $16.39B $2.89B 17.64%
2013-09-30 $16.14B $2.54B 15.71%
2013-06-30 $15.81B $2.29B 14.48%
2013-03-31 $16.20B $2.82B 17.39%
2012-12-31 $17.62B $4.17B 23.66%
2012-09-30 $18.88B $5.37B 28.46%
2012-06-30 $20.49B $6.57B 32.06%
2012-03-31 $21.48B $7.28B 33.88%
2011-12-31 $21.24B $6.98B 32.86%
2011-09-30 $20.90B $6.86B 32.81%
2011-06-30 $20.35B $6.67B 32.77%
2011-03-31 $19.69B $6.43B 32.68%
2010-12-31 $19.48B $6.07B 31.16%
2010-09-30 $19.41B $5.73B 29.53%
2010-06-30 $19.40B $5.63B 29.01%
2010-03-31 $19.29B $5.51B 28.58%
2009-12-31 $18.81B $5.32B 28.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $98.088B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $245.380B 17.90
Amgen (AMGN) United States $157.535B 13.42
Gilead Sciences (GILD) United States $146.403B 15.24
Vertex Pharmaceuticals (VRTX) United States $99.962B 25.77
CSL (CSLLY) Australia $85.454B 0.00
GSK (GSK) United Kingdom $79.612B 9.26
Regeneron Pharmaceuticals (REGN) United States $60.827B 14.80
Alnylam Pharmaceuticals (ALNY) United States $59.886B 0.00
Argenex SE (ARGX) Netherlands $40.473B 71.19
BioNTech SE (BNTX) Germany $27.057B 0.00
Insmed (INSM) United States $26.902B 0.00
Royalty Pharma (RPRX) United States $20.948B 8.18
Biogen (BIIB) United States $19.926B 8.49
Incyte (INCY) United States $16.583B 21.12
Illumina (ILMN) United States $15.451B 24.17
Genmab (GNMSF) Denmark $15.349B 13.59
Genmab (GMAB) Denmark $15.025B 13.70
Ascendis Pharma (ASND) Denmark $11.880B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.029B 15.57
Moderna (MRNA) United States $10.929B 0.00
QIAGEN (QGEN) Netherlands $10.814B 20.74
Swedish Orphan Biovitrum (BIOVF) Sweden $10.313B 22.81
Exelixis (EXEL) United States $10.165B 18.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.006B 0.00
Exact Sciences (EXAS) United States $8.536B 0.00
Bio-Techne Corp (TECH) United States $8.354B 30.80
Halozyme Therapeutics (HALO) United States $8.066B 14.19
Roivant Sciences (ROIV) United Kingdom $8.029B 0.00
Anbio Biotechnology (NNNN) Germany $7.435B 0.00
Guardant Health (GH) United States $7.416B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.138B 38.08
Repligen (RGEN) United States $6.980B 76.12
Legend Biotech (LEGN) United States $6.882B 0.00
Revolution Medicines (RVMD) United States $6.814B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Rhythm Pharmaceuticals (RYTM) United States $6.515B 0.00
Avidity Biosciences (RNA) United States $5.723B 0.00
Axsome Therapeutics (AXSM) United States $5.546B 0.00
Nuvalent (NUVL) United States $5.409B 0.00
Abivax SA (ABVX) France $5.289B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.238B 0.00
Merus (MRUS) Netherlands $4.992B 0.00
Viking Therapeutics (VKTX) United States $4.733B 0.00
Cytokinetics (CYTK) United States $4.661B 0.00
Alkermes (ALKS) Ireland $4.641B 12.90
Ascentage Pharma Group - (AAPG) China $4.414B 0.00
TG Therapeutics (TGTX) United States $4.400B 74.95
Zealand Pharma (ZLDPF) Denmark $4.332B 4.28
Krystal Biotech (KRYS) United States $4.234B 29.74
ACADIA Pharmaceuticals (ACAD) United States $4.228B 39.16
ADMA Biologics Inc (ADMA) United States $4.207B 30.40
Vaxcyte (PCVX) United States $4.166B 0.00
Telix Pharmaceuticals (TLX) Australia $4.027B 0.00
Arcellx (ACLX) United States $3.983B 0.00
Zai Lab (ZLAB) United States $3.964B 0.00
PTC Therapeutics (PTCT) United States $3.956B 6.57
Akero Therapeutics (AKRO) United States $3.887B 0.00
Protagonist Therapeutics (PTGX) United States $3.497B 80.30
Apellis Pharmaceuticals (APLS) United States $3.454B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.451B 0.00
Metsera (MTSR) United States $3.403B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.350B 0.00
Jyong Biotech (MENS) Taiwan $3.155B 0.00
Kymera Therapeutics (KYMR) United States $3.119B 0.00
Scholar Rock Holding (SRRK) United States $3.030B 0.00
Ligand Pharmaceuticals (LGND) United States $3.003B 0.00
Bavarian Nordic (BVNRY) Denmark $2.936B 15.51
Xenon Pharmaceuticals (XENE) Canada $2.916B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.866B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.862B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.753B 0.00
Alvotech (ALVO) Luxembourg $2.713B 20.45
Immunovant (IMVT) United States $2.660B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.499B 843.00
Recursion Pharmaceuticals (RXRX) United States $2.397B 0.00
Liquidia Technologies (LQDA) United States $2.386B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.305B 0.00
ImmunityBio (IBRX) United States $2.297B 0.00
Amicus Therapeutics (FOLD) United States $2.284B 0.00
Celcuity (CELC) United States $2.188B 0.00
Agios Pharmaceuticals (AGIO) United States $2.176B 0.00
IDEAYA Biosciences (IDYA) United States $2.169B 0.00
Denali Therapeutics (DNLI) United States $2.167B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.095B 11.74
Belite Bio (BLTE) United States $2.068B 0.00
Sarepta Therapeutics (SRPT) United States $2.051B 0.00
Disc Medicine (IRON) United States $2.046B 0.00
Mesoblast (MESO) Australia $2.039B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.007B 0.00
CG Oncology (CGON) United States $1.992B 0.00
ANI Pharmaceuticals (ANIP) United States $1.947B 17.45
Adaptive Biotechnologies (ADPT) United States $1.890B 0.00
Vericel (VCEL) United States $1.833B 302.67
Certara (CERT) United States $1.796B 32.88
Beam Therapeutics (BEAM) United States $1.730B 0.00
Apogee Therapeutics (APGE) United States $1.701B 0.00
Biohaven (BHVN) United States $1.694B 0.00
Twist Bioscience (TWST) United States $1.691B 0.00
Travere Therapeutics (TVTX) United States $1.673B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.628B 0.00
Celldex Therapeutics (CLDX) United States $1.626B 0.00
Cidara Therapeutics (CDTX) United States $1.604B 0.00
Novavax (NVAX) United States $1.577B 4.26
WAVE Life Sciences (WVE) Singapore $1.550B 0.00
Janux Therapeutics (JANX) United States $1.534B 0.00
Viridian Therapeutics (VRDN) United States $1.479B 0.00
Edgewise Therapeutics (EWTX) United States $1.475B 0.00
89BIO (ETNB) United States $1.400B 0.00
AbCellera Biologics (ABCL) Canada $1.396B 0.00
Vera Therapeutics (VERA) United States $1.391B 0.00
Cogent Biosciences (COGT) United States $1.379B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.367B 0.00
NovoCure (NVCR) Jersey $1.352B 0.00
Dynavax Technologies (DVAX) United States $1.262B 53.80
CureVac (CVAC) Germany $1.223B 5.68
GRAIL (GRAL) United States $1.182B 0.00
MannKind (MNKD) United States $1.169B 34.64
Pharvaris (PHVS) Netherlands $1.159B 0.00
Intellia Therapeutics (NTLA) United States $1.152B 0.00
Structure Therapeutics (GPCR) United States $1.150B 0.00
Pacira BioSciences (PCRX) United States $1.118B 11.85
Arcus Biosciences (RCUS) United States $1.114B 0.00
LENZ Therapeutics (LENZ) United States $1.106B 0.00
MiMedx (MDXG) United States $1.064B 23.97
Zymeworks (ZYME) United States $1.056B 0.00
Spyre Therapeutics (SYRE) United States $1.023B 0.00
Mineralys Therapeutics (MLYS) United States $1.017B 0.00
Stoke Therapeutics (STOK) United States $1.014B 21.78
Nuvation Bio (NUVB) United States $0.993B 0.00
Praxis Precision Medicines (PRAX) United States $0.981B 0.00
CorMedix Inc (CRMD) United States $0.978B 17.47
Upstream Bio (UPB) United States $0.971B 0.00
Oric Pharmaceuticals (ORIC) United States $0.962B 0.00
Sionna Therapeutics (SION) United States $0.944B 0.00
Geron (GERN) United States $0.919B 0.00
Trevi Therapeutics (TRVI) United States $0.907B 0.00
Iovance Biotherapeutics (IOVA) United States $0.905B 0.00
Urogen Pharma (URGN) United States $0.898B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Immunome (IMNM) United States $0.892B 0.00
Precigen (PGEN) United States $0.879B 0.00
UniQure (QURE) Netherlands $0.859B 0.00
Pharming Group (PHAR) Netherlands $0.849B 0.00
Anavex Life Sciences (AVXL) United States $0.824B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.817B 0.00
Sana Biotechnology (SANA) United States $0.809B 0.00
Niagen Bioscience (NAGE) United States $0.807B 77.85
NeoGenomics (NEO) United States $0.806B 0.00
Tango Therapeutics (TNGX) United States $0.803B 0.00
BGM Group (BGM) China $0.792B 0.00
Oculis Holding AG (OCS) Switzerland $0.789B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.781B 0.00
ArriVent BioPharma (AVBP) United States $0.781B 0.00
Nurix Therapeutics (NRIX) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.778B 0.00
Gyre Therapeutics (GYRE) United States $0.756B 157.00
Immatics (IMTX) Germany $0.755B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.742B 0.00
Zenas BioPharma (ZBIO) United States $0.728B 0.00
Fortrea Holdings (FTRE) United States $0.719B 12.77
Phathom Pharmaceuticals (PHAT) United States $0.717B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.712B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.698B 0.00
Dianthus Therapeutics (DNTH) United States $0.675B 0.00
GH Research (GHRS) Ireland $0.659B 0.00
Kura Oncology (KURA) United States $0.649B 0.00
Arbutus Biopharma (ABUS) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
MeiraGTx Holdings (MGTX) United States $0.641B 0.00
Bicara Therapeutics (BCAX) United States $0.626B 0.00
Vir Biotechnology (VIR) United States $0.622B 0.00
Castle Biosciences (CSTL) United States $0.596B 58.74
Kodiak Sciences (KOD) United States $0.594B 0.00
Terns Pharmaceuticals (TERN) United States $0.592B 0.00
Keros Therapeutics (KROS) United States $0.590B 46.84
Maze Therapeutics (MAZE) United States $0.585B 0.00
Tyra Biosciences (TYRA) United States $0.574B 0.00
Rezolute (RZLT) United States $0.570B 0.00
AnaptysBio (ANAB) United States $0.561B 0.00
Palvella Therapeutics (PVLA) United States $0.548B 0.00
Rapport Therapeutics (RAPP) United States $0.533B 0.00
Myriad Genetics (MYGN) United States $0.531B 0.00
Arvinas (ARVN) United States $0.526B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.522B 0.00
Septerna (SEPN) United States $0.517B 0.00
Cytek Biosciences (CTKB) United States $0.517B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.500B 0.00
Verastem (VSTM) United States $0.491B 0.00
MBX Biosciences (MBX) United States $0.489B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.486B 0.00
Emergent Biosolutions (EBS) United States $0.484B 3.96
ATyr Pharma (ATYR) United States $0.481B 0.00
PureTech Health (PRTC) United States $0.479B 0.00
Prime Medicine (PRME) United States $0.471B 0.00
Cullinan Therapeutics (CGEM) United States $0.470B 0.00
Solid Biosciences (SLDB) United States $0.470B 0.00
Tectonic Therapeutic (TECX) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
Gossamer Bio (GOSS) United States $0.452B 0.00
ITeos Therapeutics (ITOS) United States $0.447B 0.00
REGENXBIO (RGNX) United States $0.440B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.440B 0.00
Inventiva S.A (IVA) France $0.439B 0.00
Eton Pharmaceuticals (ETON) United States $0.439B 0.00
Erasca (ERAS) United States $0.434B 0.00
Absci (ABSI) United States $0.423B 0.00
Replimune (REPL) United States $0.416B 0.00
I-Mab (IMAB) United States $0.416B 0.00
Aura Biosciences (AURA) United States $0.416B 0.00
Kamada (KMDA) Israel $0.412B 21.09
Compass Therapeutics (CMPX) United States $0.397B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.396B 0.00
Olema Pharmaceuticals (OLMA) United States $0.395B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.387B 0.00
XOMA Royalty (XOMA) United States $0.384B 0.00
Astria Therapeutics (ATXS) United States $0.383B 0.00
Northwest Biotherapeutics (NWBO) United States $0.376B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.370B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.365B 0.00
Fulcrum Therapeutics (FULC) United States $0.359B 0.00
Abeona Therapeutics (ABEO) United States $0.354B 7.51
CytomX Therapeutics (CTMX) United States $0.350B 3.79
Inhibrx Biosciences (INBX) United States $0.346B 0.00
Amarin (AMRN) Ireland $0.335B 0.00
Benitec Biopharma (BNTC) United States $0.334B 0.00
Candel Therapeutics (CADL) United States $0.327B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.327B 0.00
Bright Minds Biosciences (DRUG) United States $0.321B 0.00
Design Therapeutics (DSGN) United States $0.308B 0.00
Ocugen (OCGN) United States $0.304B 0.00
DiaMedica Therapeutics (DMAC) United States $0.298B 0.00
Cartesian Therapeutics (RNAC) United States $0.293B 0.00
Neurogene (NGNE) United States $0.292B 0.00
Foghorn Therapeutics (FHTX) United States $0.288B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.282B 12.67
Atea Pharmaceuticals (AVIR) United States $0.280B 0.00
Humacyte (HUMA) United States $0.279B 0.00
Lifecore Biomedical (LFCR) United States $0.277B 0.00
DBV Technologies S.A (DBVT) France $0.274B 0.00
Codexis (CDXS) United States $0.271B 0.00
Crescent Biopharma (CBIO) United States $0.270B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.269B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.267B 0.00
Neumora Therapeutics (NMRA) United States $0.266B 0.00
Alumis (ALMS) United States $0.264B 0.00
Prima BioMed (IMMP) Australia $0.261B 0.00
Vor Biopharma (VOR) $0.258B 0.00
Annexon (ANNX) United States $0.258B 0.00
ScPharmaceuticals (SCPH) United States $0.255B 0.00
Puma Biotechnology (PBYI) United States $0.252B 5.11
Editas Medicine (EDIT) United States $0.245B 0.00
Allogene Therapeutics (ALLO) United States $0.242B 0.00
Alpha Teknova (TKNO) United States $0.236B 0.00
Tvardi Therapeutics (TVRD) United States $0.232B 0.00
Sagimet Biosciences (SGMT) United States $0.232B 0.00
Adherex Technologies (FENC) United States $0.228B 0.00
Contineum Therapeutics (CTNM) United States $0.227B 0.00
Aardvark Therapeutics (AARD) United States $0.227B 0.00
GENFIT S.A (GNFT) France $0.225B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.223B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.221B 0.00
CARGO Therapeutics (CRGX) United States $0.216B 0.00
AC Immune (ACIU) Switzerland $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Alector (ALEC) United States $0.216B 0.00
Voyager Therapeutics (VYGR) United States $0.213B 0.00
Monopar Therapeutics (MNPR) United States $0.211B 0.00
Entrada Therapeutics (TRDA) United States $0.210B 0.00
Innate Pharma S.A (IPHA) France $0.206B 0.00
Tenaya Therapeutics (TNYA) United States $0.205B 0.00
C4 Therapeutics (CCCC) United States $0.204B 0.00
Ventyx Biosciences (VTYX) United States $0.202B 0.00
Instil Bio (TIL) United States $0.195B 0.00
Rapt Therapeutics (RAPT) United States $0.194B 0.00
Elicio Therapeutics (ELTX) United States $0.192B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.191B 0.00
EnGene Holdings (ENGN) Canada $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.182B 0.00
Sangamo Therapeutics (SGMO) United States $0.178B 0.00
Tevogen Bio Holdings (TVGN) United States $0.177B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
Nkarta (NKTX) United States $0.167B 0.00
Nuvectis Pharma (NVCT) United States $0.164B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Cabaletta Bio (CABA) United States $0.162B 0.00
Cardiff Oncology (CRDF) United States $0.162B 0.00
Cellectis S.A (CLLS) France $0.161B 0.00
Greenwich LifeSciences (GLSI) United States $0.161B 0.00
BioHarvest Sciences (BHST) Canada $0.158B 0.00
Black Diamond Therapeutics (BDTX) United States $0.157B 11.96
Eledon Pharmaceuticals (ELDN) United States $0.155B 0.00
Seres Therapeutics (MCRB) United States $0.155B 0.00
TuHURA Biosciences (HURA) United States $0.155B 0.00
Kyverna Therapeutics (KYTX) United States $0.153B 0.00
MaxCyte (MXCT) United States $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Agenus (AGEN) United States $0.144B 0.00
Climb Bio (CLYM) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.140B 0.00
Fate Therapeutics (FATE) United States $0.138B 0.00
Compugen (CGEN) Israel $0.138B 0.00
IO Biotech (IOBT) Denmark $0.138B 0.00
Citius Oncology (CTOR) United States $0.137B 0.00
Alpha Cognition (ACOG) Canada $0.136B 0.00
Scilex Holding (SCLX) United States $0.135B 0.00
Genelux (GNLX) United States $0.134B 0.00
Immuneering (IMRX) United States $0.127B 0.00
Anika Therapeutics (ANIK) United States $0.125B 0.00
Coherus Oncology (CHRS) United States $0.124B 0.00
Zura Bio (ZURA) United States $0.119B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.118B 0.00
Seer (SEER) United States $0.116B 0.00
BioStem Technologies (BSEM) $0.110B 5.74
Cognition Therapeutics (CGTX) United States $0.109B 0.00
Spero Therapeutics (SPRO) United States $0.107B 0.00
Connect Biopharma Holdings (CNTB) United States $0.107B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.106B 0.00
Skye Bioscience (SKYE) United States $0.105B 0.00
VistaGen Therapeutics (VTGN) United States $0.104B 0.00
Biomea Fusion (BMEA) United States $0.104B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
TScan Therapeutics (TCRX) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
23andMe Holding (MEHCQ) United States $0.099B 0.00
Celularity (CELU) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
XBiotech (XBIT) United States $0.098B 0.00
Immunic (IMUX) United States $0.097B 0.00
Pliant Therapeutics (PLRX) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
Adagene (ADAG) China $0.092B 0.00
Alto Neuroscience (ANRO) United States $0.092B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
CervoMed (CRVO) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
OKYO Pharma (OKYO) $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.087B 0.00
Elutia (ELUT) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
Forte Biosciences (FBRX) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.078B 0.00
Whitehawk Therapeutics (WHWK) United States $0.076B 0.00
Artiva Biotherapeutics (ARTV) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.075B 0.00
Applied Therapeutics (APLT) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Invivyd (IVVD) United States $0.070B 0.00
Inovio Pharmaceuticals (INO) United States $0.070B 0.00
Opus Genetics (IRD) United States $0.069B 0.00
TELA Bio (TELA) United States $0.067B 0.00
INmune Bio (INMB) United States $0.067B 0.00
Fortress Biotech (FBIO) United States $0.067B 0.00
Adlai Nortye (ANL) Cayman Islands $0.066B 0.00
Ovid Therapeutics (OVID) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Genenta Science S.p.A (GNTA) Italy $0.065B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Adverum Biotechnologies (ADVM) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.061B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
Adicet Bio (ACET) United States $0.060B 0.00
Earth Science Tech (ETST) United States $0.060B 0.00
KALA BIO (KALA) United States $0.060B 0.00
Quantum Biopharma (QNTM) Canada $0.060B 0.00
ImageneBio (IMA) United States $0.059B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
MiNK Therapeutics (INKT) United States $0.058B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
ABVC BioPharma (ABVC) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
ALX Oncology Holdings (ALXO) United States $0.052B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
Equillium (EQ) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Alterity Therapeutics - (ATHE) Australia $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.045B 0.00
Generation Bio (GBIO) United States $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
PepGen (PEPG) United States $0.043B 0.00
Clene (CLNN) United States $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
Exicure (XCUR) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Radiopharm Theranostics - (RADX) Australia $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Renovaro (RENB) United States $0.040B 0.00
Rani Therapeutics Holdings (RANI) United States $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
CAMP4 Therapeutics (CAMP) United States $0.038B 0.00
Pluri (PLUR) Israel $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
BioXcel Therapeutics (BTAI) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.034B 0.00
Clearside Biomedical (CLSD) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Kezar Life Sciences (KZR) United States $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.027B 0.00
Medicus Pharma (MDCX) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Rallybio (RLYB) United States $0.026B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Passage Bio (PASG) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Curis (CRIS) United States $0.022B 0.00
Soligenix (SNGX) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Dare Bioscience (DARE) United States $0.019B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.019B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.015B 0.00
X4 Pharmaceuticals (XFOR) United States $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Beyond Air (XAIR) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Tharimmune (THAR) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00